AIG
47
6
XRX
34
-3
KHC
17
4
SIG
47
-2
DOV
73
4
COF
63
-4
BAX
27
-2
CF
53
2
VZ
42
3
DFS
67
-3
GIS
29
3
LNC
45
-4
CMG
69
-3
HRL
30
-3
LB
63
-4
FOX
57
-3
NKE
33
2
LOW
58
2
CTSH
65
-3
BA
45
-3
AIG
47
6
XRX
34
-3
KHC
17
4
SIG
47
-2
DOV
73
4
COF
63
-4
BAX
27
-2
CF
53
2
VZ
42
3
DFS
67
-3
GIS
29
3
LNC
45
-4
CMG
69
-3
HRL
30
-3
LB
63
-4
FOX
57
-3
NKE
33
2
LOW
58
2
CTSH
65
-3
BA
45
-3
Financhill
Back

Evoke Pharma 10K Form

Sell
13

EVOK
Evoke Pharma

Last Price:
4.56
Seasonality Move:
12.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-14 10Q EVOK/Evoke Pharma Quarterly
2023-11-09 10Q EVOK/Evoke Pharma Quarterly
2023-08-10 10Q EVOK/Evoke Pharma Quarterly
2023-05-15 10Q EVOK/Evoke Pharma Quarterly
2022-11-09 10Q EVOK/Evoke Pharma Quarterly
2022-08-10 10Q EVOK/Evoke Pharma Quarterly

Receive EVOK News And Ratings

See the #1 stock for the next 7 days that we like better than EVOK

EVOK Financial Statistics

Sales & Book Value

Annual Sales: $5.18M
Cash Flow: $-820.6K
Price / Cash Flow: 0
Annual Sales: $3.63
Price / Book: 1.38

Profitability

EPS (TTM): -26.40000
Net Income (TTM): $-6.53M
Gross Margin: $4.98M
Return on Equity: -1005.23%
Return on Assets: -67.32%

Evoke Pharma Earnings Forecast

Key Evoke Pharma Financial Ratios

  • The Gross Profit Margin over the past 13 years for EVOK is 96.10%.
  • The Selling, General & Administrative Expenses for EVOK have been equal to 236.03% of Gross Profit Margin.
  • The Research & Development expenses have been 3.51% of Revenue.
  • The Interest Expense is -6.42% of Operating Income.
  • The Net Earning history of EVOK is -150.41% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 10 years.

Evoke Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: EVOK
CUSIP: 30049G
Website: evokepharma.com

Debt

Debt-to-Equity Ratio: 1.88
Current Ratio: 1.28
Quick Ratio: 1.18

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 10.42

EVOK Technical Analysis vs Fundamental Analysis

Sell
13
Evoke Pharma (EVOK) is a Sell

Is Evoke Pharma a Buy or a Sell?

  • Evoke Pharma stock is rated a Sell
    The current Evoke Pharma [EVOK] share price is $4.30. The Score for EVOK is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.